An observational study in Coagulopathy, Cardiac Surgery, Cardiopulmonary Bypass, sponsored by Mahidol University. Completed at 2 sites in Thailand. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-17.
Sponsored by Mahidol University · Observational
Coagulopathy in cardiac surgery; a quaternary-care academic center experience
Objectives:
Primary:
To determine incidence of coagulopathy after cardiac surgery in Thai people To determine incidence of resternotomy for stop bleeding, morbidity and mortality
Secondary:
To identify risk factors which associated with non-red cell transfusion and coagulopathy
study decide: Retrospective chart review
Data to be collected:
Age*, gender* Body weight, height, body mass index* Underlying disease: DM, renal disease*, liver disease* Pre-op. Antiplatelet or anticoagulant* Pre-op coagulogram and platelet count* Emergency or elective surgery Resternotomy or not* Intraoperative blood component Intraoperative factor concentration Dose and timing of antifibrinolytic administration* CPB time* Postoperative body temperature*
*Possible risk factors for non-red cell transfusion
statistic: To assess the relationship between risk factors and non-red cell transfusion a univariate analysis was performed using an unpaired t-test and a Chi-square test.
For higher accuracy regarding the impact of single risk factors, a multiple logistic regression analysis was also performed.
Age ≥ 18 years Schedule to cardiac surgery under cardiopulmonary bypass
Exclusion Criteria:
incidence of coagulopathy after cardiac surgery in Thai people
coagulopathy and throbocytopenia
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mahidol University